Medicinal product name Venclyxto
Pharmaceutical form Film-coated tablet
Strength 50 mg 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.II onk. ķīm. ter., hem.)
 Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
Risk minimisation measuresIzglītojošie materiāli pacientam Izglītojošie materiāli pacientam
Vēstule veselības aprūpes speciālistam Vēstule veselības aprūpes speciālistam
ATC code L01XX52 Antineoplastic agents

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N5: 5 × 1
(50 mg)
PVC/PE/PCTFE/aluminium blister    EU/1/16/1138/003  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/16/1138/003
Date of authorisation Dec 5, 2016
MA valid until For unlimited time
Marketing authorisation holder, country AbbVie Deutschland GmbH & Co. KG, Germany